SynsoryBio
New accelerator entry · 2024-02-08 · the record
In their words
SynsoryBio is creating next generation, protein therapeutics that sense where they are in the body and only activate at diseased tissue. This technology platform has the potential to expand the therapeutic window of highly potent drugs and apply to many diseases such as cancer and autoimmune disorders.
What the record says
The full profile
Source Check, INVEST, RECRUIT and Press Requests on SynsoryBio
- Source Check — verify what SynsoryBio states, against the registers that hold it.
- INVEST — size up this company on the figures its record states.
- RECRUIT — see who is already on the team.
- Press Requests — connect with SynsoryBio for a story.
You land back on this company when you are in.
Not ready to upgrade? Keep this one in view instead.
Watchlist SynsoryBioYou get an alert in MentionFox the next time this company shows up.
Is this you?
If you're behind SynsoryBio: acceptance into a YC batch is one of the few weeks a young company gets looked up by people who matter — investors, other founders, press. FoxPlug turns the commits, deploys, and releases you're already making into that story automatically, so anyone who looks finds something current. FoxChat puts a guide on your own site so the people YC's own page just sent you don't read one line and leave.
Sourced from the company's Y Combinator directory entry.